🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nolan A. Wages

Virginia Commonwealth University

ORCID: 0000-0002-2190-4864

Also affiliated with Virginia Cancer Institute, University of Virginia

MathematicsDecision SciencesMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma”.

MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma

Frontiers in Oncology(2021)10.3389/fonc.2020.585551
N/A
0DataRank · unranked
18 citations

Nolan A. Wages, Patrick A. Grant, P. Todd Stukenberg, Ryan D. Gentzler, Richard D. Hall +9 more

Quasi-partial order continual reassessment method: Applying toxicity scores to cancer dose-finding drug combination trials

(2022)10.1016/j.cct.2022.107050
N/A
0DataRank · unranked
0 citations

Nolan A. Wages, Elizabeth Garrett‐Mayer, Nathaniel S. O’Connell

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia

eJHaem(2023)10.1002/jha2.663
N/A
0DataRank · unranked
18 citations

Graeme Murray, Michael Doyel, Tilak Patel, Josh Boron, Valerie Tran +9 more

Dose-finding based on feasibility and late-onset toxicity in adoptive cell therapy trials

Journal of Biopharmaceutical Statistics(2023)10.1080/10543406.2023.2183507
N/A
0DataRank · unranked
4 citations

Nolan A. Wages, Evan Bagley

Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

Research Square(2023)10.21203/rs.3.rs-3015916/v1
N/A
0DataRank · unranked
4 citations

Graeme Murray, Thuy Ho, Michael Doyel, Tilak Patel, Josh Boron +10 more

Current issues in dose-finding designs: A response to the US Food and Drug Adminstration’s Oncology Center of Excellence Project Optimus

Clinical Trials(2024)10.1177/17407745241234652
N/A
0DataRank · unranked
8 citations

Elizabeth Garrett‐Mayer, Nolan A. Wages, Susan Halabi, Ying Kuen Cheung, Peter F. Thall

Clonal Evolution in 207 Cases of Refractory or Relapsed Acute Myeloid Leukemia

European Journal Of Haematology(2024)10.1111/ejh.14308
N/A
0DataRank · unranked
5 citations

Ian Bouligny, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan A. Wages +3 more

Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.20.581048
N/A
0DataRank · unranked
1 citations

Nardin Ageeb, Joseph M. Obeid, Ileana S. Mauldin, Kate A. Goundry, Gabriel F. Hanson +9 more

Understanding the Role of Patient-Reported Outcomes for Decision-Making in Early-Phase Dose-Finding Clinical Trials

Current Oncology(2025)10.3390/curroncol32030176
N/A
0DataRank · unranked
4 citations

Nolan A. Wages, Emily Liu, Arnethea L. Sutton, Andrew Poklepovic, Richard Brown